drugset / Trial / NCT03302650
Angiotensin II for Septic Shock Treatment
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study aims to investigate the effect of angiotensin II on microcirculation and peripheral perfusion in patients with septic shock.
Timeline
- Start
- 2019-04-01
- Primary completion
- 2019-08-01
- Completion
- 2019-08-15
Outcome
Outcome not reported
Stopped: “The drug is not available”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Angiotensin II | Peptide | 20 ng | — |
| Background | Norepinephrine | Other / unclassified | 0.7 ug/kg | — |